ALKERMES reported $16.41M in Pre-Tax Profit for its fourth fiscal quarter of 2020.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -14.79M 28.61M
Biogen BIIB:US $ 814.2M 255M
Bluebird Bio BLUE:US $ -216.93M 14.49M
Bristol Myers Squibb BMY:US $ 5289M 67M
Coherus Biosciences CHRS:US $ -38.53M 11.22M
Eli Lilly And LLY:US $ 1470.5M 518.1M
H. Lundbeck A/S LUN:DC 643M 159M
Intra Cellular Therapies ITCI:US $ -76.93M 8.21M
IONIS PHARMACEUT IONS:US $ -84M 3M
Johnson & Johnson JNJ:US $ 8058M 282M
Marinus Pharmaceuticals MRNS:US $ -19.51M 4.32M
Minerva Neurosciences NERV:US $ -9.2M 1.38M
Nektar Therapeutics NKTR:US $ -129.59M 4.43M
Neurocrine Biosciences NBIX:US $ 30.5M 27M
Otsuka Holdings 4578:JP Y 47101M 14105M
Regeneron Pharmaceuticals REGN:US $ 1822.2M 2076.1M
Revance Therapeutics RVNC:US $ -74.38M 2.18M
Teva Pharmaceutical Industries TEVA:US $ 807M 13M
Zogenix ZGNX:US $ -58M 0.89M